Rapid Quantification of Gabapentin, Pregabalin, and Vigabatrin in Human Serum by Ultraperformance Liquid Chromatography With Mass-Spectrometric Detection

Gabapentin (GBP), pregabalin (PRG), and vigabatrin (VIG) are used for the prevention and treatment of epileptic seizures. The developed method was applied to samples from subjects participating in a pharmacokinetic study of GBP. Sample pretreatment consisted of adding 20 μL of trichloroacetic acid (...

Full description

Saved in:
Bibliographic Details
Published in:Therapeutic drug monitoring Vol. 35; no. 1; pp. 48 - 53
Main Authors: CHAHBOUNI, Abdel, SINJEWEL, Arno, DEN BURGER, Jeroen C. G, VOS, René M, WILHELM, Abraham J, VELDKAMP, Agnes I, SWART, Eleanora L
Format: Journal Article
Language:English
Published: Hagerstown, MD Lippincott Williams & Wilkins 01-02-2013
Lippincott Williams & Wilkins Ovid Technologies
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Gabapentin (GBP), pregabalin (PRG), and vigabatrin (VIG) are used for the prevention and treatment of epileptic seizures. The developed method was applied to samples from subjects participating in a pharmacokinetic study of GBP. Sample pretreatment consisted of adding 20 μL of trichloroacetic acid (30%; vol/vol) and 200 μL of GBP-d4 in acetonitrile as an internal standard to 20 μL of serum. Chromatographic separation was performed on an Acquity separation module using a Kinetex RP18 column. The aqueous and organic mobile phases were 2 mM ammonium acetate supplemented with 0.1% formic acid in water and acetonitrile, respectively. The detection by a tandem quadrupole mass spectrometer, operating in the positive mode using multiple reaction monitoring, was completed within 2 minutes. The method was linear over the range of 0.03-25 mg/L for GBP, 0.03-25 mg/L for PRG, and 0.06-50 mg/L for VIG. The between- and within-run accuracies ranged from 90% to 107%. The between- and within-run imprecisions of the method were <10%. Stability data show no significant decrease of the analytes. A relative matrix effect of -1%, 0.2%, and -5% was determined for GBP, PRG, and VIG, respectively. A simple and sensitive ultraperformance liquid chromatography-tandem mass spectrometry method was developed and validated for the simultaneous quantification of GBP, PRG, and VIG in human serum. The reported method provided the necessary linearity, precision, and accuracy to allow the determination of GBP, PRG, and VIG for therapeutic drug monitoring and clinical research purposes.
AbstractList BACKGROUNDGabapentin (GBP), pregabalin (PRG), and vigabatrin (VIG) are used for the prevention and treatment of epileptic seizures. The developed method was applied to samples from subjects participating in a pharmacokinetic study of GBP.METHODSSample pretreatment consisted of adding 20 μL of trichloroacetic acid (30%; vol/vol) and 200 μL of GBP-d4 in acetonitrile as an internal standard to 20 μL of serum. Chromatographic separation was performed on an Acquity separation module using a Kinetex RP18 column. The aqueous and organic mobile phases were 2 mM ammonium acetate supplemented with 0.1% formic acid in water and acetonitrile, respectively. The detection by a tandem quadrupole mass spectrometer, operating in the positive mode using multiple reaction monitoring, was completed within 2 minutes.RESULTSThe method was linear over the range of 0.03-25 mg/L for GBP, 0.03-25 mg/L for PRG, and 0.06-50 mg/L for VIG. The between- and within-run accuracies ranged from 90% to 107%. The between- and within-run imprecisions of the method were <10%. Stability data show no significant decrease of the analytes. A relative matrix effect of -1%, 0.2%, and -5% was determined for GBP, PRG, and VIG, respectively.CONCLUSIONSA simple and sensitive ultraperformance liquid chromatography-tandem mass spectrometry method was developed and validated for the simultaneous quantification of GBP, PRG, and VIG in human serum. The reported method provided the necessary linearity, precision, and accuracy to allow the determination of GBP, PRG, and VIG for therapeutic drug monitoring and clinical research purposes.
Gabapentin (GBP), pregabalin (PRG), and vigabatrin (VIG) are used for the prevention and treatment of epileptic seizures. The developed method was applied to samples from subjects participating in a pharmacokinetic study of GBP. Sample pretreatment consisted of adding 20 μL of trichloroacetic acid (30%; vol/vol) and 200 μL of GBP-d4 in acetonitrile as an internal standard to 20 μL of serum. Chromatographic separation was performed on an Acquity separation module using a Kinetex RP18 column. The aqueous and organic mobile phases were 2 mM ammonium acetate supplemented with 0.1% formic acid in water and acetonitrile, respectively. The detection by a tandem quadrupole mass spectrometer, operating in the positive mode using multiple reaction monitoring, was completed within 2 minutes. The method was linear over the range of 0.03-25 mg/L for GBP, 0.03-25 mg/L for PRG, and 0.06-50 mg/L for VIG. The between- and within-run accuracies ranged from 90% to 107%. The between- and within-run imprecisions of the method were <10%. Stability data show no significant decrease of the analytes. A relative matrix effect of -1%, 0.2%, and -5% was determined for GBP, PRG, and VIG, respectively. A simple and sensitive ultraperformance liquid chromatography-tandem mass spectrometry method was developed and validated for the simultaneous quantification of GBP, PRG, and VIG in human serum. The reported method provided the necessary linearity, precision, and accuracy to allow the determination of GBP, PRG, and VIG for therapeutic drug monitoring and clinical research purposes.
Gabapentin (GBP), pregabalin (PRG), and vigabatrin (VIG) are used for the prevention and treatment of epileptic seizures. The developed method was applied to samples from subjects participating in a pharmacokinetic study of GBP. Sample pretreatment consisted of adding 20 ...L of trichloroacetic acid (30%; vol/vol) and 200 ..L of GBP-d4 in acetonitrile as an internal standard to 20 ...L of serum. Chromatographic separation was performed on an Acquity separation module using a Kinetex RP18 column. The aqueous and organic mobile phases were 2 mM ammonium acetate supplemented with 0.1% formic acid in water and acetonitrile, respectively. The detection by a tandem quadrupole mass spectrometer, operating in the positive mode using multiple reaction monitoring, was completed within 2 minutes. The method was linear over the range of 0.03-25 mg/L for GBP, 0.03-25 mg/L for PRG, and 0.06-50 mg/L for VIG. The between- and within-run accuracies ranged from 90% to 107%. The between- and within-run imprecisions of the method were <10%. Stability data show no significant decrease of the analytes. A relative matrix effect of -1%, 0.2%, and -5% was determined for GBP, PRG, and VIG, respectively. A simple and sensitive ultraperformance liquid chromatography-tandem mass spectrometry method was developed and validated for the simultaneous quantification of GBP, PRG, and VIG in human serum. The reported method provided the necessary linearity, precision, and accuracy to allow the determination of GBP, PRG, and VIG for therapeutic drug monitoring and clinical research purposes. (ProQuest: ... denotes formulae/symbols omitted.)
Author CHAHBOUNI, Abdel
SINJEWEL, Arno
VOS, René M
VELDKAMP, Agnes I
SWART, Eleanora L
WILHELM, Abraham J
DEN BURGER, Jeroen C. G
Author_xml – sequence: 1
  givenname: Abdel
  surname: CHAHBOUNI
  fullname: CHAHBOUNI, Abdel
  organization: Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands
– sequence: 2
  givenname: Arno
  surname: SINJEWEL
  fullname: SINJEWEL, Arno
  organization: Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands
– sequence: 3
  givenname: Jeroen C. G
  surname: DEN BURGER
  fullname: DEN BURGER, Jeroen C. G
  organization: Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands
– sequence: 4
  givenname: René M
  surname: VOS
  fullname: VOS, René M
  organization: Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands
– sequence: 5
  givenname: Abraham J
  surname: WILHELM
  fullname: WILHELM, Abraham J
  organization: Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands
– sequence: 6
  givenname: Agnes I
  surname: VELDKAMP
  fullname: VELDKAMP, Agnes I
  organization: Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands
– sequence: 7
  givenname: Eleanora L
  surname: SWART
  fullname: SWART, Eleanora L
  organization: Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27062519$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23188183$$D View this record in MEDLINE/PubMed
BookMark eNpdkd1q3DAQhUVJaTZp36AUQSn0Ik4ly5Ksy7BpksKW_iRpL40sj7MKtuRI8sU-St82Mtm2EBBIM_OdmUHnCB047wCht5ScUqLkp4ub81PSEsqA0bqUsq4NeYFWlDNRMKGqA7QiVLCiYlwcoqMY7wmhVU3IK3RYZklNa7ZCf37qyXb4x6xdsr01OlnvsO_xpW71BDnpTvD3AHc5HJa3dh3-ZZcwBetwPlfzqB2-hjCPuN3h2yGFrAy9DzlvAG_sw5xHrLfBjzr5u1zd7vBvm7b4q46xuJ7ApFyD3NDgc0g5zEu8Ri97PUR4s7-P0e3F55v1VbH5dvllfbYpDBM8FSBEX_HSSCNIBb0SUnUd14KLEninupIbIlvR5QoY0iqpe2MYMS1IMFIpdow-PvWdgn-YIaZmtNHAMGgHfo4NLSXjVaXqBX3_DL33c3B5u4UiXJaqrjNVPVEm-BgD9M0U7KjDrqGkWaxrsnXNc-uy7N2--dyO0P0T_fUqAx_2gI5GD33Iv2vjf04SUXKq2CMP86a1
CODEN TDMODV
CitedBy_id crossref_primary_10_1097_FTD_0000000000000516
crossref_primary_10_2174_1573412914666171228160833
crossref_primary_10_1177_0003702817716181
crossref_primary_10_1016_j_jpba_2020_113172
crossref_primary_10_1093_jat_bku004
crossref_primary_10_1016_j_chroma_2016_08_057
crossref_primary_10_1080_10408347_2020_1855411
crossref_primary_10_1080_10408347_2021_1916733
crossref_primary_10_1016_j_toxac_2020_10_019
crossref_primary_10_1002_cpt_1353
crossref_primary_10_1016_j_saa_2020_119021
crossref_primary_10_1093_jat_bku010
crossref_primary_10_1097_FTD_0000000000000325
crossref_primary_10_3390_separations10040234
crossref_primary_10_1002_bmc_5023
crossref_primary_10_1007_s40262_014_0177_7
crossref_primary_10_3390_separations8020021
crossref_primary_10_1016_j_seizure_2017_09_015
crossref_primary_10_1093_chromsci_bmab031
crossref_primary_10_1002_dta_1733
crossref_primary_10_1038_clpt_2013_108
crossref_primary_10_1016_j_chroma_2017_04_049
crossref_primary_10_1016_j_jchromb_2014_05_037
crossref_primary_10_1016_j_jpba_2016_09_036
crossref_primary_10_1093_jat_bkt081
Cites_doi 10.1365/s10337-007-0440-2
10.1021/ac020361s
10.1016/j.seizure.2005.11.005
10.1081/JLC-100101455
10.1016/j.jpba.2010.02.036
10.1097/01.ftd.0000158874.54100.1a
10.1016/j.jchromb.2005.11.009
10.1016/j.cell.2009.09.025
10.1093/chromsci/47.10.868
10.1111/j.1528-1167.2008.01561.x
10.1016/S0074-7696(02)13011-7
10.1016/S1570-0232(04)00662-2
10.1023/A:1007669411738
10.1016/j.clinthera.2007.01.013
10.1016/S0378-4347(97)00521-5
10.1111/j.1365-2710.2010.01243.x
10.1002/jssc.200800461
ContentType Journal Article
Copyright 2014 INIST-CNRS
Copyright Lippincott Williams & Wilkins Feb 2013
Copyright_xml – notice: 2014 INIST-CNRS
– notice: Copyright Lippincott Williams & Wilkins Feb 2013
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
7X8
DOI 10.1097/FTD.0b013e31827788c0
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1536-3694
EndPage 53
ExternalDocumentID 2868318601
10_1097_FTD_0b013e31827788c0
23188183
27062519
Genre Journal Article
Feature
GroupedDBID ---
.-D
.GJ
.Z2
0R~
123
1CY
3O-
4Q1
4Q2
4Q3
53G
5RE
5VS
71W
8L-
8W4
AAHPQ
AAMTA
AAPBV
AARTV
AAYEP
ABASU
ABBUW
ABDIG
ABFLS
ABOCM
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFO
ACGFS
ACWDW
ACWRI
ACXNZ
ADFPA
ADNKB
AE3
AE6
AENEX
AFDTB
AFFNX
AHMBA
AHVBC
AJIOK
AJNYG
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AWKKM
BQLVK
BS7
C45
CS3
DIWNM
DU5
DUNZO
E.X
EBS
EJD
EX3
F2K
F2L
F5P
FL-
GQDEL
H0~
HZ~
IKREB
IN~
IPNFZ
IQODW
J5H
JK3
JK8
K8S
KD2
KMI
L-C
N9A
N~M
O9-
OAG
OAH
OCUKA
ODA
OJAPA
OL1
OLG
OLV
OLW
OLZ
OPC
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQEST
PQQKQ
R58
RIG
RLZ
S4R
S4S
TEORI
TSPGW
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
XXN
XYM
YFH
YOC
ZFV
ZGI
ZXP
ZY1
ZZMQN
AAAAV
AAIQE
AASCR
ABJNI
ABVCZ
ACILI
ACXJB
ADGGA
ADHPY
AEETU
AHQNM
AINUH
AJNWD
AJZMW
AMNEI
AOHHW
CGR
CUY
CVF
ECM
EEVPB
EIF
FCALG
GNXGY
HLJTE
NPM
AAYXX
CITATION
K9.
7X8
ID FETCH-LOGICAL-c365t-e66f452c7c604ef9679dd5a6562e5d9d25c07b6df96ec0b97afcc30cbe7ec7993
ISSN 0163-4356
IngestDate Fri Aug 16 07:50:18 EDT 2024
Thu Oct 10 17:25:03 EDT 2024
Fri Aug 23 00:19:06 EDT 2024
Sat Sep 28 08:00:10 EDT 2024
Thu Nov 24 18:30:56 EST 2022
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Human
Biological fluid
LC―MS
4-Aminobutyrate transaminase
Gabapentin
Enzyme
Transferases
Enzyme inhibitor
HPLC chromatography
Exploration
Anticonvulsant
Liquid chromatography
Pregabalin
Analgesic
Vigabatrin
Transaminases
Serum
Diagnosis
Detection
Mass spectrometry
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c365t-e66f452c7c604ef9679dd5a6562e5d9d25c07b6df96ec0b97afcc30cbe7ec7993
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 23188183
PQID 1270572988
PQPubID 31802
PageCount 6
ParticipantIDs proquest_miscellaneous_1273544989
proquest_journals_1270572988
crossref_primary_10_1097_FTD_0b013e31827788c0
pubmed_primary_23188183
pascalfrancis_primary_27062519
PublicationCentury 2000
PublicationDate 2013-02-01
PublicationDateYYYYMMDD 2013-02-01
PublicationDate_xml – month: 02
  year: 2013
  text: 2013-02-01
  day: 01
PublicationDecade 2010
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
– name: New York
PublicationTitle Therapeutic drug monitoring
PublicationTitleAlternate Ther Drug Monit
PublicationYear 2013
Publisher Lippincott Williams & Wilkins
Lippincott Williams & Wilkins Ovid Technologies
Publisher_xml – name: Lippincott Williams & Wilkins
– name: Lippincott Williams & Wilkins Ovid Technologies
References Berry (R10-4-20210129) 2005; 27
Rosing (R16-4-20210129) 2000; 23
Eroglu (R3-4-20210129) 2009; 139
Patsalos (R21-4-20210129) 2008; 49
Mandal (R12-4-20210129) 2008; 67
Watanabe (R2-4-20210129) 2002; 213
Wad (R8-4-20210129) 1998; 705
Tassone (R4-4-20210129) 2007; 29
Hamandi (R5-4-20210129) 2006; 15
Matuszewski (R19-4-20210129) 2003; 75
Oertel (R14-4-20210129) 2009; 32
Wattananat (R13-4-20210129) 2009; 47
Mercolini (R7-4-20210129) 2010; 53
Matuszewski (R20-4-20210129) 2006; 830
Vermeij (R11-4-20210129) 2004; 810
Shah (R15-4-20210129) 2000; 12
Yagi (R9-4-20210129) 2012; 37
References_xml – volume: 67
  start-page: 237
  year: 2008
  ident: R12-4-20210129
  article-title: . Determination of pregablin in human plasma using LC-MS-MS.
  publication-title: Chromatographia
  doi: 10.1365/s10337-007-0440-2
  contributor:
    fullname: Mandal
– volume: 75
  start-page: 3019
  year: 2003
  ident: R19-4-20210129
  article-title: Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MSMS.
  publication-title: Anal Chem
  doi: 10.1021/ac020361s
  contributor:
    fullname: Matuszewski
– volume: 15
  start-page: 73
  year: 2006
  ident: R5-4-20210129
  article-title: Pregabalin: a new antiepileptic drug for refractory epilepsy.
  publication-title: Seizure
  doi: 10.1016/j.seizure.2005.11.005
  contributor:
    fullname: Hamandi
– volume: 23
  start-page: 329
  year: 2000
  ident: R16-4-20210129
  article-title: . Bioanalytical liquid chromatography method validation. A review of current practices and procedures.
  publication-title: J Liq Chrom Rel Technol
  doi: 10.1081/JLC-100101455
  contributor:
    fullname: Rosing
– volume: 53
  start-page: 62
  year: 2010
  ident: R7-4-20210129
  article-title: . Simultaneous HPLC-F analysis of three recent antiepileptic drugs in human plasma.
  publication-title: J Pharm Biomed Anal
  doi: 10.1016/j.jpba.2010.02.036
  contributor:
    fullname: Mercolini
– volume: 27
  start-page: 451
  year: 2005
  ident: R10-4-20210129
  article-title: Analysis of pregabalin at therapeutic concentrations in human plasmaserum by reversed-phase HPLC.
  publication-title: Ther Drug Monit
  doi: 10.1097/01.ftd.0000158874.54100.1a
  contributor:
    fullname: Berry
– volume: 830
  start-page: 293
  year: 2006
  ident: R20-4-20210129
  article-title: Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis.
  publication-title: J Chromatogr B Analyt Technol Biomed Life Sci
  doi: 10.1016/j.jchromb.2005.11.009
  contributor:
    fullname: Matuszewski
– volume: 139
  start-page: 380
  year: 2009
  ident: R3-4-20210129
  article-title: . Gabapentin receptor 2-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis.
  publication-title: Cell
  doi: 10.1016/j.cell.2009.09.025
  contributor:
    fullname: Eroglu
– volume: 47
  start-page: 868
  year: 2009
  ident: R13-4-20210129
  article-title: Validated LC-MS-MS method for the determination of gabapentin in human plasma: application to a bioequivalence study.
  publication-title: J Chromatogr Sci
  doi: 10.1093/chromsci/47.10.868
  contributor:
    fullname: Wattananat
– volume: 49
  start-page: 1239
  year: 2008
  ident: R21-4-20210129
  article-title: . Antiepileptic drugsbest practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies.
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1167.2008.01561.x
  contributor:
    fullname: Patsalos
– volume: 213
  start-page: 1
  year: 2002
  ident: R2-4-20210129
  article-title: . GABA and GABA receptors in the central nervous system and other organs.
  publication-title: Int Rev Cytol
  doi: 10.1016/S0074-7696(02)13011-7
  contributor:
    fullname: Watanabe
– volume: 810
  start-page: 297
  year: 2004
  ident: R11-4-20210129
  article-title: Simultaneous high-performance liquid chromatographic analysis of pregabalin, gabapentin and vigabatrin in human serum by precolumn derivatization with o-phthaldialdehyde and fluorescence detection.
  publication-title: J Chromatogr B Anal Technol Biomed Life Sci
  doi: 10.1016/S1570-0232(04)00662-2
  contributor:
    fullname: Vermeij
– volume: 12
  start-page: 1551
  year: 2000
  ident: R15-4-20210129
  article-title: . Bioanalytical method validationa revisit with a decade of progress.
  publication-title: Pharm Res
  doi: 10.1023/A:1007669411738
  contributor:
    fullname: Shah
– volume: 29
  start-page: 26
  year: 2007
  ident: R4-4-20210129
  article-title: . Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2007.01.013
  contributor:
    fullname: Tassone
– volume: 705
  start-page: 154
  year: 1998
  ident: R8-4-20210129
  article-title: Sensitive high-performance liquid chromatographic method with fluorometric detection for the simultaneous determination of gabapentin and vigabatrin in serum and urine.
  publication-title: J Chromatogr B Biomed Sci Appl
  doi: 10.1016/S0378-4347(97)00521-5
  contributor:
    fullname: Wad
– volume: 37
  start-page: 89
  year: 2012
  ident: R9-4-20210129
  article-title: . Rapid and validated fluorometric HPLC method for determination of gabapentin in human plasma and urine for clinical application.
  publication-title: J Clin Pharm Ther
  doi: 10.1111/j.1365-2710.2010.01243.x
  contributor:
    fullname: Yagi
– volume: 32
  start-page: 238
  year: 2009
  ident: R14-4-20210129
  article-title: . Simultaneous determination of three anticonvulsants using hydrophilic interaction LC-MS.
  publication-title: J Sep Sci
  doi: 10.1002/jssc.200800461
  contributor:
    fullname: Oertel
SSID ssj0014800
Score 2.2139747
Snippet Gabapentin (GBP), pregabalin (PRG), and vigabatrin (VIG) are used for the prevention and treatment of epileptic seizures. The developed method was applied to...
BACKGROUNDGabapentin (GBP), pregabalin (PRG), and vigabatrin (VIG) are used for the prevention and treatment of epileptic seizures. The developed method was...
SourceID proquest
crossref
pubmed
pascalfrancis
SourceType Aggregation Database
Index Database
StartPage 48
SubjectTerms Amines - blood
Anticonvulsants - blood
Biological and medical sciences
Blood Chemical Analysis - methods
Chromatography
Chromatography, High Pressure Liquid - methods
Convulsions & seizures
Cyclohexanecarboxylic Acids - blood
Drug Stability
Drug use
Epilepsy
gamma-Aminobutyric Acid - analogs & derivatives
gamma-Aminobutyric Acid - blood
Humans
Mass spectrometry
Medical sciences
Pharmacology
Pharmacology. Drug treatments
Pregabalin
Tandem Mass Spectrometry - methods
Vigabatrin - blood
Title Rapid Quantification of Gabapentin, Pregabalin, and Vigabatrin in Human Serum by Ultraperformance Liquid Chromatography With Mass-Spectrometric Detection
URI https://www.ncbi.nlm.nih.gov/pubmed/23188183
https://www.proquest.com/docview/1270572988
https://search.proquest.com/docview/1273544989
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZ2eUFCiDuFMRkJ7aWN8HJxnMeytTCpbNXWTXuLEtvZgra0pAmoP4V_y7Gdy7INBA9IVVQ5TZr2fPl8fPKdcxB67yeUuY5Q7dsJt9wYNiwhxJK2lziMRoRyHbo48Q_P2f7IHa2t13302rH_amkYA1urzNl_sHZzUhiA92Bz2ILVYftXdj-OFqlQWk2jAmo8wk9RHC2UNEjTzDSXFzBQdWtXwfOzVA0Ueaqljya2D0RSXisH9fSqUFlabY7BJP1Wwteo0rrg8lZlr4Fiisv-F3DHLdXWvlCVEFQDACC1Qiu-spuu8KzN_OqLvLzoX2t6yeu51GgOLmOgI604GMZCNnKQkzT7Kn9UCoM8mzcyoj7waP-jzvU24p18DgNNKPjMqAqPgWy1QqAKBldhD9WCoiMhua98hQ57pFdaW3T0Hf6E5ulErcesYqjUscBLrCpw17xPLYeafsv1xGDqqHRuAMPypjboncnHFDUez_bb6LLt-4xx0k62tcDg8Cgcn04m4Wx0Puvu1b6FzSiDw6nKTNy0gUOBwjeHeweTg-YRmctMflX9a-q80MD_cN8ldPyuh4toCRSQmN4tv19caSdr9hg9qlZHeGhg_QStyewp2pma8uqrAb6BmeUA7-BpW3h99Qz91NjHXezjeYJb7A9wi_wBBtzjFvcYXhr3WOMexyt8G_fY4B53cY8V7vFd3OMG98_R6Xg02_tsVa1HLO5Qr7AkpYnr2dznlLgyCagfCOFFsPixpScCYXuc-DEVsEdyEgd-lHDuEB5LX3IffP4XaCObZ_IVwt4ul4QkQrUEgNVRzCSjdiAot2VEaeT0kFUbJlyYCjNhrQwBQ4a3DdlD2x3rNQfZPqEqD72HtmpzhhUxLUMlMPFgIc1YD71rdsNUop4PRpmcl_ozjue6AYNTvDQwaE8OFwC-vfP6zyd_gx60N-sW2ijyUr5F60tRblf4_QVxhfMV
link.rule.ids 315,782,786,27933,27934
linkProvider Ovid
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rapid+Quantification+of+Gabapentin%2C+Pregabalin%2C+and+Vigabatrin+in+Human+Serum+by+Ultraperformance+Liquid+Chromatography+With+Mass-Spectrometric+Detection&rft.jtitle=Therapeutic+drug+monitoring&rft.au=Chahbouni%2C+Abdel&rft.au=Sinjewel%2C+Arno&rft.au=G+den+Burger%2C+Jeroen+C&rft.au=Vos%2C+Ren%C3%A9+M&rft.date=2013-02-01&rft.pub=Lippincott+Williams+%26+Wilkins+Ovid+Technologies&rft.issn=0163-4356&rft.eissn=1536-3694&rft.volume=35&rft.issue=1&rft.spage=48&rft_id=info:doi/10.1097%2FFTD.0b013e31827788c0&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=2868318601
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0163-4356&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0163-4356&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0163-4356&client=summon